Kamada Ltd. KMDA
KMDA Rating
KMDA Rating Factors
KMDA Company Overview
Kamada Ltd. is an Israel-based biopharmaceutical company focused on specialty plasma-derived therapeutics, with operations spanning the development, manufacture, and commercialization of products targeting rare and serious medical conditions. The company primarily operates in the biotechnology and specialty pharmaceuticals industries, with a business model centered on proprietary plasma-derived protein therapeutics, contract manufacturing services, and plasma collection activities. Kamada’s revenue is generated through sales of commercial products, distribution partnerships, technology licensing, and manufacturing agreements. Its flagship commercial product portfolio has historically included therapies for alpha-1 antitrypsin deficiency, rabies post-exposure prophylaxis, and immune globulin products.
The company serves hospitals, specialty clinics, government healthcare systems, and pharmaceutical partners across multiple international markets. Kamada has developed strategic positioning through vertically integrated plasma collection and manufacturing capabilities, long-term distribution collaborations, and expertise in plasma-derived biologics production. Founded in 1990 in Israel, the company evolved from a niche plasma therapeutics developer into a diversified specialty biopharmaceutical organization with both proprietary products and contract development and manufacturing operations. Over time, Kamada expanded its commercial footprint through acquisitions, plasma collection investments, and partnerships with larger pharmaceutical distributors.
KMDA Income Statement
KMDA Balance Sheet
KMDA Price History
KMDA Valuation
KMDA Dividends and Shares
KMDA Corporate Info
Science Park
PO Box 4081
Rehovot, 7670402